Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.

Kroll JL, Beam C, Li S, Viscidi R, Dighero B, Cho A, Boulware D, Pescovitz M, Weinberg A. Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. J Clin Virol. 2013 Jun; 57(2):115-9.

View in: PubMed

subject areas

Adolescent
Adult
Antibodies, Monoclonal, Murine-Derived
BK Virus
Child
Cytomegalovirus
Cytomegalovirus Infections
Diabetes Mellitus, Type 1
DNA, Viral
Epstein-Barr Virus Infections
Female
Herpesviridae Infections
Herpesvirus 4, Human
Humans
Incidence
JC Virus
Male
Polymerase Chain Reaction
Polyomavirus Infections
Rituximab
Treatment Outcome
Tumor Virus Infections
Viremia
Virus Activation
Virus Latency
Young Adult

authors with profiles

Adriana Weinberg